| Autor: |
McKendrick, M. W., Geddes, A. M., Wise, R., Andrews, J. A. |
| Předmět: |
|
| Zdroj: |
Journal of Antimicrobial Chemotherapy (JAC); Apr1981, Vol. 7 Issue 4, p405-414, 10p |
| Abstrakt: |
Cefotaxime (HR 756) is a new broad spectrum parenteral cephalosporin which has a high degree of activity particularly against Gram-negative strains and is resistant to hydrolysis by -lactamases. The results of clinical study in 38 patients are presented. Cefotaxime was effective in treating infections due to , , haemolytic streptococci (Groups A, C and G) and . There was variable success with infections due to and two patients with typhoid fever failed to respond. Cefotaxime was well tolerated and no serious toxicity was noted. [ABSTRACT FROM PUBLISHER] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
